BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33981360)

  • 1. Comprehensive co-expression analysis reveals TMC8 as a prognostic immune-associated gene in head and neck squamous cancer.
    Lin B; Wang S; Yao Y; Shen Y; Yang H
    Oncol Lett; 2021 Jul; 22(1):498. PubMed ID: 33981360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma.
    Lin YH; Yang YF; Liao JB; Chang TS; Janesha UGS; Shiue YL
    J Cancer; 2023; 14(10):1689-1706. PubMed ID: 37476181
    [No Abstract]   [Full Text] [Related]  

  • 3. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.
    Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
    Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
    Front Genet; 2023; 14():1041042. PubMed ID: 36936420
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer.
    Lin B; Li H; Zhang T; Ye X; Yang H; Shen Y
    Aging (Albany NY); 2021 Feb; 13(4):5718-5747. PubMed ID: 33592580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma.
    Liu Z; Chen S; Jia W; Qian Y; Yang X; Zhang M; Fang T; Liu H
    Front Oncol; 2023; 13():1113781. PubMed ID: 37064086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
    Xing J; Gu Y; Song Y; Liu Q; Chen Q; Han P; Shen Z; Li H; Zhang S; Bai Y; Ma J; Sui F
    BMC Cancer; 2023 Dec; 23(1):1267. PubMed ID: 38129784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the Therapeutic and Prognostic Role of the CD8+ T Cell-Related Gene ALDH2 in Head and Neck Squamous Cell Carcinoma.
    Zhang H; Li Z; Zheng Y
    Cancer Inform; 2022; 21():11769351221139252. PubMed ID: 36570380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A coding variant in TMC8 (EVER2) is associated with high risk HPV infection and head and neck cancer risk.
    Liang C; Kelsey KT; McClean MD; Christensen BC; Marsit CJ; Karagas MR; Waterboer T; Pawlita M; Nelson HH
    PLoS One; 2015; 10(4):e0123716. PubMed ID: 25853559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between the Prognostic Marker LIMA1 in Head and Neck Squamous Cell Carcinoma and Immune Infiltration.
    Huang H; Du Y; Zhao D; Chen K
    J Oncol; 2022; 2022():1040116. PubMed ID: 37181789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of NUTF2 as a Candidate Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
    Zhang R; Gao Y
    Onco Targets Ther; 2021; 14():5455-5467. PubMed ID: 35221694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer.
    Ge H; Yan Y; Yan M; Guo L; Mao K
    Med Sci Monit; 2020 Jun; 26():e923208. PubMed ID: 32562536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma.
    Cui K; Yao X; Wei Z; Yang Y; Liu X; Huang Z; Huo H; Tang J; Xie Y
    Front Genet; 2022; 13():917344. PubMed ID: 36186458
    [No Abstract]   [Full Text] [Related]  

  • 15. Transmembrane channel-like protein 8 as a potential biomarker for poor prognosis of hepatocellular carcinoma.
    Lu P; Ding Q; Ding S; Fan Y; Li X; Tian D; Liu M
    Mol Clin Oncol; 2017 Aug; 7(2):244-248. PubMed ID: 28781795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.
    Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W
    Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of immune cell infiltration in head and neck squamous carcinoma.
    Liang B; Tao Y; Wang T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
    Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
    Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between APOBEC3H-Mediated Demethylation and Immune Landscape in Head and Neck Squamous Carcinoma.
    Liu Q; Luo YW; Cao RY; Pan X; Chen XJ; Zhang SY; Zhang WL; Zhou JY; Cheng B; Ren XY
    Biomed Res Int; 2020; 2020():4612375. PubMed ID: 32775421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
    Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
    Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.